# Barry A. Borlaug

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/barry-a-borlaug/

## Facts

| Field | Value |
| --- | --- |
| Citations | 56,389 |
| Field | Cardiovascular Function and Risk Factors |
| h-index | 121 |
| i10-index | 401 |
| Last Known Institution | Mayo Clinic |
| OpenAlex ID | https://openalex.org/A5030461468 |
| ORCID iD | 0000-0001-9375-0596 |
| Works | 830 |

## Researcher papers

Showing 12 of 17.

- [Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/semaglutide-in-patients-with-heart-failure-with-preserved-ejection-fraction-and/)
- [Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/pulmonary-hypertension-in-heart-failure-with-preserved-ejection-fraction/)
- [A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/a-simple-evidence-based-approach-to-help-guide-diagnosis-of-heart-failure-with/)
- [Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/effect-of-phosphodiesterase-5-inhibition-on-exercise-capacity-and-clinical/)
- [Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/evidence-supporting-the-existence-of-a-distinct-obese-phenotype-of-heart-failure/)
- [Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/exercise-hemodynamics-enhance-diagnosis-of-early-heart-failure-with-preserved/)
- [Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment](https://scholariq.org/papers/heart-failure-with-preserved-ejection-fraction-pathophysiology-diagnosis-and/)
- [Tricuspid Annular Displacement Predicts Survival in Pulmonary Hypertension](https://scholariq.org/papers/tricuspid-annular-displacement-predicts-survival-in-pulmonary-hypertension/)
- [Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction](https://scholariq.org/papers/phenotype-specific-treatment-of-heart-failure-with-preserved-ejection-fraction/)
- [Heart Failure With Preserved Ejection Fraction In Perspective](https://scholariq.org/papers/heart-failure-with-preserved-ejection-fraction-in-perspective/)
- [Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity](https://scholariq.org/papers/tirzepatide-for-heart-failure-with-preserved-ejection-fraction-and-obesity/)
- [Impaired Chronotropic and Vasodilator Reserves Limit Exercise Capacity in Patients With Heart Failure and a Preserved Ejection Fraction](https://scholariq.org/papers/impaired-chronotropic-and-vasodilator-reserves-limit-exercise-capacity-in/)

## Researcher topics

- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Cardiovascular and exercise physiology](https://scholariq.org/topics/cardiovascular-and-exercise-physiology/)
- [Cardiac Valve Diseases and Treatments](https://scholariq.org/topics/cardiac-valve-diseases-and-treatments/)

## Researcher university

- [Mayo Clinic](https://scholariq.org/institutions/mayo-clinic/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.